Global Miscarriage Market, By Types (Complete Miscarriage, Incomplete Miscarriage, Missed Miscarriage, Threatened Miscarriage, Inevitable Miscarriage and Septic Miscarriage), Drugs (Misoprostol, Mifepristone, Methotrexate, Progesterone and Others), Diagnosis (Pelvic Exam, Tissue Test, Chromosomal Test, Ultrasound and Blood Test), Treatment (Medication, Surgery, Supportive Care and Others), Route of Administration (Oral, Vaginal and Others), Distribution Channel (Hospital Pharmacy, Retail Pharmacy and Online Pharmacy), End User (Hospitals, Homecare, Specialty Clinics and Others) – Industry Trends and Forecast to 2030.
Miscarriage Market Analysis and Size
Major factors that are expected to boost the growth of the miscarriage market in the forecast period are the rise in the incidence of smoking and alcohol among women. Furthermore, the growing incidence of diabetes and thyroid disorders is further anticipated to propel the growth of the miscarriage market.
Data Bridge Market Research analyses that the Miscarriage Market which was USD 4,125.63 million in 2022, would rocket up to USD 6,759.21 million by 2030, and is expected to undergo a CAGR of 4.2% during the forecast period. This indicates that the market value. “Complete Miscarriage” dominates the type segment of the Miscarriage Market owing to the high prevalence of this type of miscarriage. In addition to the insights on market scenarios such as market value, growth rate, segmentation, geographical coverage, and major players, the market reports curated by the Data Bridge Market Research also include depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework.
Miscarriage Market Scope and Segmentation
|
Report Metric
|
Details
|
|
Forecast Period
|
2023 to 2030
|
|
Base Year
|
2022
|
|
Historic Years
|
2021 (Customizable to 2015 - 2020)
|
|
Quantitative Units
|
Revenue in USD Million, Volumes in Units, Pricing in USD
|
|
Segments Covered
|
Types (Complete Miscarriage, Incomplete Miscarriage, Missed Miscarriage, Threatened Miscarriage, Inevitable Miscarriage and Septic Miscarriage), Drugs (Misoprostol, Mifepristone, Methotrexate, Progesterone and Others), Diagnosis (Pelvic Exam, Tissue Test, Chromosomal Test, Ultrasound and Blood Test), Treatment (Medication, Surgery, Supportive Care and Others), Route of Administration (Oral, Vaginal and Others), Distribution Channel (Hospital Pharmacy, Retail Pharmacy and Online Pharmacy), End User (Hospitals, Homecare, Specialty Clinics and Others)
|
|
Countries Covered
|
U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.
|
|
Market Players Covered
|
Abbott Laboratories (U.S.), Amgen (U.S.), Actavis (Ireland), Bayer (Germany), Ferring Pharmaceuticals (Switzerland), GlaxoSmithKline (U.K.), Johnson & Johnson (U.S.), Merck & Co. (U.S.), Pfizer Inc. (U.S.)., Procter & Gamble (U.S.), Roche (Switzerland), Sanofi (France), Novartis AG (Switzerland), Shionogi & Co. (Japan), Sun Pharmaceutical Industries (India), Thermo Fisher Scientific (US), Watson Pharmaceuticals (U.S.)
|
|
Market Opportunities
|
|
Market Definition
Miscarriage can be known as the impulsive ending of a pregnancy. About half of miscarriage happens within the first trimester before 20 week’s gestation. Recurrent miscarriage continues can be a difficult reproductive challenge for the patient and clinician.
Global Miscarriage Market Dynamics
Drivers
- Rising incidences of smoking and alcohol among women
Growing incidences of smoking and alcohol among women is among the essential factors intensifying the growth and demand of miscarriage market. This in turn has carved the way for the growth of the market.
- Research and development proficiencies
Rising expenditure for research and development proficiencies, especially in the developed and developing economies pertaining to medical drugs and devices, will further create lucrative market growth opportunities. Research and development proficiencies being conducted to develop medical drugs is also bolstering the market growth rate.
- Growing investment for healthcare facilities
Surging focus on improving the condition of healthcare facilities and improving the overall healthcare infrastructure is another important factor fostering the growth of the market. The rising number of partnerships and strategic collaborations between the public and private players pertaining to funding and application of new and improved technology is further creating lucrative market opportunities.
Opportunities
Furthermore, an upsurge in the public-private funding for target research activities, rising prevalence of diabetes and thyroid disorders and rising product innovations and development owing to technological advancements all around the world will extend profitable opportunities for the market players in the forecast period of 2023 to 2030. Likewise, the rise in worldwide healthcare expenses will further provide potential opportunities for the growth of the Miscarriage market in the coming years.
Restraints/Challenges
On the other hand, rise in the price of treatment, high cost associated with the research and development proficiencies, and limited infrastructural facilities, which is further projected to impede the growth of the Miscarriage market in the timeline period and dearth of awareness in the backward economies are expected to obstruct market growth. Also, the lack of favorable reimbursement scenarios and technology penetration in the developing economies and lack of suitable infrastructure in low- and middle-income countries are projected to challenge the market in the forecast period of 2023-2030.
This miscarriage market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, the impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the miscarriage market, contact Data Bridge Market Research for an Analyst Brief. Our team will help you make an informed market decision to achieve market growth.
Recent Developments
- In July 2021, Ferring Pharmaceuticals announced the approval of its drug, Carbetocin, by the US FDA for the prevention of excessive bleeding after childbirth, which can also be used to prevent uterine bleeding following a miscarriage.
- In February 2021, Merck announced the launch of its new product, Gavi, a fertility hormone that can be used to help women who have experienced recurrent miscarriages.
- In January 2021, Abbott Laboratories announced that it had received approval from the US FDA for its new prenatal screening test, which can detect chromosomal abnormalities that may cause miscarriage.
Global Miscarriage Market Scope
The miscarriage market is segmented on the basis of type, drugs, diagnosis, treatment, route of administration, end users and distribution channel. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.
Type
- Complete Miscarriage
- Incomplete Miscarriage
- Missed Miscarriage
- Threatened Miscarriage
- Inevitable Miscarriage
- Septic Miscarriage
Drugs
- Misoprostol
- Mifepristone
- Methotrexate
- Progesterone
- Others
Diagnosis
- Pelvic Exam
- Tissue Test
- Chromosomal Test
- Ultrasound
- Blood Test
Treatment
- Medication
- Surgery
- Supportive Care
- Others
Route of Administration
- Oral
- Vaginal
- Others
End Users
- Hospitals
- Homecare
- Specialty Clinics
- Others
Distribution Channel
- Retail Pharmacy
- Hospital Pharmacy
- Online Pharmacy
Miscarriage Market Regional Analysis/Insights
The miscarriage market is analysed and market size insights and trends are provided by country, type, drug, diagnosis, treatment, route of administration, end user and distribution channel, as referenced above.
The countries covered in the miscarriage market report are U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.
North America is expected to dominate the miscarriage market because of the strong base of healthcare facilities, the strong presence of major players in the market, increased cases of thyroid disorders among the population and rising number of research activities in this region.
Asia-Pacific is expected to witness significant growth during the forecast period of 2023 to 2030 due to the increase in government initiatives to promote awareness, rise in healthcare facilities, growing research activities in the region, availability of massive untapped markets, large population pool, and the growing demand for quality healthcare in the region.
The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points like down-stream and upstream value chain analysis, technical trends and porter's five forces analysis, and case studies are some of the pointers used to forecast the market scenario for individual countries. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, the impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.
Healthcare Infrastructure Growth Installed Base and New Technology Penetration
The miscarriage market also provides you with a detailed market analysis for every country's growth in healthcare expenditure for capital equipment, the installed base of different kinds of products for the miscarriage market, the impact of technology using lifeline curves and changes in healthcare regulatory scenarios and their impact on the miscarriage market. The data is available for the historic period 2015-2020.
Competitive Landscape and Miscarriage Market Share Analysis
The miscarriage market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies' focus related to miscarriage market.
Some of the major players operating in the miscarriage market are:
- Novartis AG (Switzerland)
- Abbott Laboratories (U.S.)
- Amgen (U.S.)
- Actavis (Ireland)
- Bayer (Germany)
- Ferring Pharmaceuticals (Switzerland)
- GlaxoSmithKline (U.K.)
- Johnson & Johnson (U.S.)
- Merck & Co. (U.S.)
- Pfizer Inc. (U.S.)
- Procter & Gamble (U.S.)
- Roche (Switzerland)
- Sanofi (France)
- Shionogi & Co. (Japan)
- Sun Pharmaceutical Industries (India)
- Thermo Fisher Scientific (US)
- Watson Pharmaceuticals (U.S.)
SKU-